BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6619640)

  • 1. [Clinical and histopathological studies on radiotherapy for hypopharyngeal carcinoma--factors determining the outcome of the therapy].
    Takashima H; Amatsu M
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):906-15. PubMed ID: 6619640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radical radiotherapy in carcinoma of the hypopharynx].
    Bertoni F; Stucchi F; Terraneo F; Scandolaro L; Cazzaniga F; Premoli A; Piantanida R
    Acta Otorhinolaryngol Ital; 1985; 5(2):185-96. PubMed ID: 4050406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radiotherapy and curietherapy of squamous cell carcinoma of the posterior pharyngeal wall (excluding the nasopharynx)].
    Chenal C; Julienne V; Fleury F; Desprez P
    Bull Cancer Radiother; 1996; 83(1):54-9. PubMed ID: 8679282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiotherapy of pharyngeal cancer--clinical results and need for calculation of dosage in several planes].
    Lessel A; Standke E; Staude G; Merkle K; Wiener A; Buth K
    Radiobiol Radiother (Berl); 1989; 30(4):341-3. PubMed ID: 2798795
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histological evaluation of pre-operative radiation in squamous cell carcinomas of the tonsil, the base of the tongue and the hypopharynx (author's transl)].
    Schumann K; Laniado K; Mittermayer C; Wannenmacher M; Daumann G
    Laryngol Rhinol Otol (Stuttg); 1980 Jun; 59(6):335-40. PubMed ID: 7453437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapeutic management of carcinoma of the posterior pharyngeal wall.
    Wang CC
    Cancer; 1971 Apr; 27(4):894-6. PubMed ID: 5574077
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth and spread of laryngeal and hypopharyngeal carcinoma with reflections on the effect of preoperative irradiation. 139 cases studied by whole organ serial sectioning.
    Olofsson J; van Nostrand AW
    Acta Otolaryngol Suppl; 1973; 308():1-84. PubMed ID: 4521065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radiotherapy for carcinoma of the hypopharynx and cervical esophagus].
    Gotoh M; Ohkawa T; Watanabe N; Kita M; Sekiguchi K; Ikeda M; Ishii T; Endo M
    Rinsho Hoshasen; 1984 Jul; 29(7):771-7. PubMed ID: 6492428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiotherapy results in advanced hypopharyngeal tumors].
    Müller RP; Schertel L
    Strahlenther Onkol; 1986 Jan; 162(1):13-6. PubMed ID: 3945914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postirradiation induration as a prognosticator. A retrospective analysis of squamous-cell carcinomas of the oral cavity and oropharynx.
    Fazekas JT; Green JP; Vaeth JM; Schroeder AF
    Radiology; 1972 Feb; 102(2):409-12. PubMed ID: 5009950
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoepithelioma (undifferentiated carcinoma) of the laryngohypopharynx.
    Stanley RJ; Weiland LH; DeSanto LW; Neel HB
    Laryngoscope; 1985 Sep; 95(9 Pt 1):1077-81. PubMed ID: 4033331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planned preoperative irradiation and surgery for advanced cancer of the oral cavity, pharynx and larynx.
    Roswit B; Spiro RH; Kolson H; Lin PY
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):59-62. PubMed ID: 5009416
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with malignant laryngeal and pharyngeal neoplasms].
    Pogosov VS; Sarkisova FR; Smetanin IG
    Vestn Otorinolaringol; 1995; (4):5-8. PubMed ID: 7676564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early response of oral, oropharyngeal, hypopharyngeal and laryngeal cancer related to local control and survival.
    Dawes PJ
    Br J Cancer Suppl; 1980 Apr; 4():14-6. PubMed ID: 6932917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation therapy of epipharyngeal cancer].
    Sasauchi S; Yamada S; Kusakari J; Kikuchi A
    Rinsho Hoshasen; 1987 Jan; 32(1):33-6. PubMed ID: 3573359
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: a study of surgical margins.
    Lee JG
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(1):ORL49-53. PubMed ID: 4813646
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinoma of the hypopharynx.
    Keane TJ
    J Otolaryngol; 1982 Aug; 11(4):227-31. PubMed ID: 7131632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-energy radiotherapy in the treatment of epitheliomas of the hypopharynx].
    Ennuyer A; Bataini P
    Acta Otorhinolaryngol Belg; 1973; 27(8):1017-24. PubMed ID: 4206792
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoma of the hypopharynx.
    Raven RW
    Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):173-7. PubMed ID: 4810294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.